These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 30668365)

  • 1. Exploring pharmacological mechanisms of Xueshuan-Xinmai-Ning tablets acting on coronary heart disease based on drug target-disease gene interaction network.
    Mao X; Xu H; Li S; Su J; Li W; Guo Q; Wang P; Guo R; Xiao X; Zhang Y; Yang H
    Phytomedicine; 2019 Feb; 54():159-168. PubMed ID: 30668365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Main active constituent identification in Guanxinjing capsule, a traditional Chinese medicine, for the treatment of coronary heart disease complicated with depression.
    Zhang YQ; Guo QY; Li QY; Ren WQ; Tang SH; Wang SS; Liang RX; Li DF; Zhang Y; Xu HY; Yang HJ
    Acta Pharmacol Sin; 2018 Jun; 39(6):975-987. PubMed ID: 28858293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the mechanism of Shengmai Yin for coronary heart disease based on systematic pharmacology and chemoinformatics.
    Jiang Y; He Q; Zhang T; Xiang W; Long Z; Wu S
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32436944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the mechanism of TCM formulae in the treatment of different types of coronary heart disease by network pharmacology and machining learning.
    Yang J; Tian S; Zhao J; Zhang W
    Pharmacol Res; 2020 Sep; 159():105034. PubMed ID: 32565312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental evidence and network pharmacology-based analysis reveal the molecular mechanism of Tongxinluo capsule administered in coronary heart diseases.
    Li G; Xu Q; Han K; Yan W; Huang C
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32990315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying potential quality markers of Xin-Su-Ning capsules acting on arrhythmia by integrating UHPLC-LTQ-Orbitrap, ADME prediction and network target analysis.
    Guo R; Zhang X; Su J; Xu H; Zhang Y; Zhang F; Li D; Zhang Y; Xiao X; Ma S; Yang H
    Phytomedicine; 2018 May; 44():117-128. PubMed ID: 29526583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network pharmacology-based identification of key pharmacological pathways of Yin-Huang-Qing-Fei capsule acting on chronic bronchitis.
    Yu G; Zhang Y; Ren W; Dong L; Li J; Geng Y; Zhang Y; Li D; Xu H; Yang H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():85-94. PubMed ID: 28053519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Integrated strategy for biomarkers of stable coronary heart disease with phlegm and blood stasis syndrome based on RNA-seq and network pharmacology].
    Yang G; Zhou SY; Wang J; Hu J; Pan JH
    Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1908-1915. PubMed ID: 37282967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network pharmacology-based prediction of the active ingredients and mechanism of Shen Gui capsule for application to coronary heart disease.
    Wang D; Tian L; Shi C; Wei YX; Wang H; Liu TT; Gong M; Zhang YW; Yu RG; Wu XH
    Comput Biol Med; 2020 Jul; 122():103825. PubMed ID: 32658730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the pharmacological mechanism of the Chinese formula huanglian-jie-du decoction in the treatment of ischemic stroke using a systems biology-based strategy.
    Zhang YQ; Wang SS; Zhu WL; Ma Y; Zhang FB; Liang RX; Xu HY; Yang HJ
    Acta Pharmacol Sin; 2015 Jun; 36(6):724-33. PubMed ID: 25937634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering Key Pharmacological Pathways of Qingdai Acting on Chronic Myeloid Leukemia Using a Network Pharmacology-Based Strategy.
    Li H; Liu L; Liu C; Zhuang J; Zhou C; Yang J; Gao C; Liu G; Lv Q; Sun C
    Med Sci Monit; 2018 Aug; 24():5668-5688. PubMed ID: 30108199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of phospholipid peroxidation signaling by a traditional Chinese medicine formula for coronary heart disease.
    Ma X; Wang Q; Liu C; Liu J; Luo G; He L; Yuan T; He RR; Yao Z
    Phytomedicine; 2023 Jun; 114():154749. PubMed ID: 36931097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of Baihe Decoction in the treatment of coronary heart disease based on network pharmacology and molecular docking.
    Jin Y; Yin X; Li Z; Xu J
    Ann Palliat Med; 2021 Mar; 10(3):3205-3218. PubMed ID: 33849106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of the mechanisms and major bioactive compounds responsible for the protective effects of Gualou Xiebai Decoction on coronary heart disease by network pharmacology analysis.
    Li C; Zhang WY; Yu Y; Cheng CS; Han JY; Yao XS; Zhou H
    Phytomedicine; 2019 Mar; 56():261-268. PubMed ID: 30668346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the chemical profile and pharmacological mechanisms of Baihu-Guizhi decoction using ultra-fast liquid chromatography-quadrupole-time-of-flight tandem mass spectrometry coupled with network pharmacology-based investigation.
    Li W; Mao X; Wu H; Guo M; Su X; Lu J; Guo Q; Li T; Wang X; Su W; Zhang Y; Lin N
    Phytomedicine; 2020 Feb; 67():153156. PubMed ID: 31901568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Xiong-Pi-Fang in treating coronary heart disease associated with depression: A systematic pharmacology strategy and in vivo pharmacological validation.
    Deng F; Li X; Tang C; Chen J; Fan B; Liang J; Zhen X; Tao R; Zhang S; Cong Z; Du W; Zhao H; Xu L
    J Ethnopharmacol; 2022 Nov; 298():115631. PubMed ID: 35987411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation.
    Qin T; Wu L; Hua Q; Song Z; Pan Y; Liu T
    J Ethnopharmacol; 2020 Jan; 246():112128. PubMed ID: 31386888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis.
    Yu G; Wang W; Wang X; Xu M; Zhang L; Ding L; Guo R; Shi Y
    BMC Complement Altern Med; 2018 Nov; 18(1):292. PubMed ID: 30382864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis on disease burden and direct medical cost of Xueshuan Xinmaining Tablets in patients with cerebral infarction and coronary heart disease].
    Hu J; Gao SQ; Wang J; Li J; Chen HW; Dai ZQ; Liao X
    Zhongguo Zhong Yao Za Zhi; 2021 May; 46(9):2309-2316. PubMed ID: 34047135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ["Multi-component-multi-target-multi-pathway" mechanism of Kuihua Hugan Tablets based on network pharmacology].
    Shen HB; Zhou YN; Zheng J; Zhu RH
    Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(7):1464-1474. PubMed ID: 31090306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.